MoleSense advances women’s healthcare with molecular wearables—a new class of medical devices that go beyond tracking vital signs to continuously and non-invasively monitor biochemical markers such as proteins and hormones.
By integrating personalized molecular data with biology-aware machine intelligence, our wearables provide proactive healthcare, starting with reproductive health.
25.06.2026
MoleSense enters Biopôle’s Investment Programme (startupticker.ch)
24.06.2026
The Swiss National Medtech Team 2026 is set for Boston (startupticker.ch)
28.05.2026
Eight Swiss startups receive international recognition (startupticker.ch)
02.04.2026
BIND 2026 Crowns Four Swiss Health Gems (startupticker.ch)
19.03.2026
FIT recognition for Diverssity, MoleSense and Performance MouthGard (startupticker.ch)
No milestones
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.molesense.ch/
Headquarter:
Epalinges
Foundation Date:
August 2025
Technology:
Sectors: